CLPT
ClearPoint Neuro, Inc.
NASDAQ · USHealthcareMedical - Devices
$15.05-0.66%
Price as of Jul 20, 2026
CLPT profitability
ClearPoint Neuro, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 61.8%
- EBITDA margin
- -58.2%
- EBIT margin
- -65.2%
- Net margin
- -71.6%
- Free cash flow margin
- -65.8%
Returns
- Return on equity
- -154.3%
- Return on assets
- -31.1%
- Return on invested capital
- -32.1%
- Asset turnover
- 0.42x
Cash efficiency
- Cash from operations
- -$25.7M
- Cash per share
- $1.19
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.